Figure 1From: Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients Rash and pigmentaion on face (a), neck (b), limbs (c) and abdominal wall (d). Back to article page